Global Breast Cancer Market 2015 Edition- Research Focus on Regions like the US, Brazil, Europe and APAC Countries and Driven by Various Factors, Major Issues and Growth Drivers

Global Breast Cancer Market Report: 2015 Edition Size and Share Published in 2015-08-11 Available for US$ 800 at


Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer are being female and growing older.

In the past few years, the cases of breast cancer have increased tremendously in regions like the US and the Europe. The breast cancer market is driven by various factors like aging female population, obesity and diabetes, dense breast tissues, healthcare expenditure, exposure to X-Ray and Gamma Radiations, Estrogen-Progestin Therapy (EPT) and increased consumption of alcohol and tobacco. A major trend which will probably remain eternally in the breast cancer treatment industry is the fact that novel and innovative technologies and pharmaceutical molecules are always under development. Challenges associated with breast cancer are like, financial burdens associated with the treatment and adverse effects of Aromatase Inhibitors (AI) on patients.

Get a Sample Copy of the Report:

The market for breast cancer drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative breast cancer drugs. Further, the companies are forming alliances and agreements to develop effective treatment methods for breast cancer.

The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, Brazil, Europe and APAC Countries. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules. The leading players operating in the industry include Hologic, Johnson and Johnson, Siemens AG, Roche and Novartis which are also profiled in this report.

Inquiry on this report:

Table of Content

1. Market Overview

1.1 Breast Cancer

1.2 Types of Breast Cancer

1.3 Risk Factors

1.4 Symptoms of Breast Cancer

1.5 Diagnosis and Treatment of Breast Cancer

1.5.1 Breast Cancer Screening and Diagnostic Measures

1.5.2 Breast Cancer Treatment

2. Breast Cancer Market

2.1 Global Market

Diagnostics Market

Therapeutic Market

Market Segmentation

3. Regional Markets

3.1 The U.S. Breast Cancer Market

3.1.1 The U.S. Breast Cancer Diagnostics Market

3.1.2 The U.S. Breast Cancer Therapeutic Market

3.1.3 The U.S. Metastatic Breast Cancer Market

3.2. Brazilian Breast Cancer Market

3.2.1 Brazilian Breast Cancer Diagnostic Market

3.2.2 Brazilian Breast Cancer Therapeutic Market

3.3 APAC Countries

3.3.1 APAC Diagnostic Market

3.3.2 APAC Therapeutic Market

3.4 European Breast Cancer Market

3.4.1 European Breast Cancer Diagnostic Market

3.4.2 European Metastatic Breast Cancer Market

Browse All Healthcare Market Research Reports at:

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948